H35.179
Retrolental fibroplasia, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retrolental fibroplasia, also known as retinopathy of prematurity (ROP), is a serious eye condition that primarily affects premature infants. It involves abnormal growth of blood vessels in the retina, which can lead to vision impairment or blindness if left untreated. The ICD-10 code H35.179 refers to retrolental fibroplasia of an unspecified eye, indicating that the specific eye affected has not been documented. This condition requires careful medical attention to prevent long-term damage.
Causes & Symptoms
Clinical Causes: Premature birth: Infants born significantly before the due date are at higher risk. Low birth weight: Babies weighing less than 3.3 pounds (1500 grams) are more susceptible. High oxygen therapy: Excessive oxygen treatment during neonatal care can contribute to abnormal blood vessel growth in the retina. Genetic factors: Certain genetic predispositions may influence the development of retrolental fibroplasia. Abrupt changes in oxygen levels: Fluctuations in oxygen exposure can also impact retinal blood vessel development.
Key Symptoms: None in early stages: Often, there are no noticeable symptoms initially. Visual impairment: As the disease progresses, blurry vision or difficulty focusing may occur. Strabismus: Misalignment of the eyes might develop. Leukocoria: An abnormal white reflection from the retina, sometimes observed in photographs. Potential total vision loss: In advanced cases without intervention, blindness may result.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by a pediatric ophthalmologist. This examination may include:
Treatment Protocols: The management of retrolental fibroplasia depends on the severity and stage of the condition. Common treatments include:
Clinical Advice & FAQs
Billing Guidance
Is H35.179 a billable ICD-10 code?
Yes, H35.179 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.179?
Clinical documentation must specify the nature of Retrolental fibroplasia, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference